Myomo (MYO) Research & Development (2016 - 2025)
Myomo's (MYO) quarterly Research & Development came in at $5.3 million in Q3 2025, up 54.48% YoY from $3.4 million in Q3 2024, and little changed on a QoQ basis from $5.2 million in Q2 2025.
Myomo (MYO) Research & Development (2016 - 2025) Analysis & Trends
Myomo (MYO) has 10 years of Research & Development data on file, last reported at $5.3 million in Q3 2025.
- Quarterly Research & Development rose 54.48% year-over-year to $5.3 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $18.6 million (up 70.57% YoY) and the FY2024 annual result came in at $12.2 million, up 35.32% from the prior year.
- Research & Development held at $5.3 million in Q3 2025, from $5.2 million in the prior quarter.
- In the past five years, Research & Development ranged from a high of $5.3 million in Q3 2025 to a low of $499674.0 in Q4 2022.
- A 5-year average of $2.2 million and a median of $2.3 million in 2023 frame the typical range for Research & Development.
- Annual changes were most pronounced in 2022 — Research & Development slumped 36.56% — and 2023, when it jumped 370.93%.
- Tracing MYO's Research & Development over 5 years: stood at $787628.0 in 2021, then plunged by 36.56% to $499674.0 in 2022, then jumped by 370.93% to $2.4 million in 2023, then soared by 57.1% to $3.7 million in 2024, then surged by 42.13% to $5.3 million in 2025.
- The last three Research & Development figures came in at $5.3 million (Q3 2025), $5.2 million (Q2 2025), and $4.4 million (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.49 Bn | 193.88 Bn | 7.27 Bn | 892.00 Mn |
| 2 | Stryker | 127.80 Bn | 124.32 Bn | 4.50 Bn | 434.00 Mn |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn | 671.00 Mn |
| 4 | Boston Scientific | 73.58 Bn | 73.04 Bn | 3.85 Bn | 554.00 Mn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 278.90 Mn |
| 6 | Dexcom | 34.34 Bn | 32.39 Bn | 830.00 Mn | 153.00 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.66 Bn | 2.18 Bn | 323.00 Mn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | -562.58 Mn |
| 9 | Steris | 23.07 Bn | 22.59 Bn | 684.20 Mn | 28.60 Mn |
| 10 | Myomo | 71.47 Mn | 52.51 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 5.25 Mn |
| Jun 30, 2025 | 5.23 Mn |
| Mar 31, 2025 | 4.40 Mn |
| Dec 31, 2024 | 3.70 Mn |
| Sep 30, 2024 | 3.40 Mn |
| Jun 30, 2024 | 2.78 Mn |
| Mar 31, 2024 | 2.36 Mn |
| Dec 31, 2023 | 2.35 Mn |
| Sep 30, 2023 | 2.39 Mn |
| Jun 30, 2023 | 2.27 Mn |
| Mar 31, 2023 | 2.03 Mn |
| Dec 31, 2022 | 499,674.00 |
| Sep 30, 2022 | 690,407.00 |
| Jun 30, 2022 | 632,872.00 |
| Mar 31, 2022 | 659,536.00 |
| Dec 31, 2021 | 787,628.00 |
| Sep 30, 2021 | 641,228.00 |
| Jun 30, 2021 | 600,116.00 |
| Mar 31, 2021 | 525,967.00 |
| Dec 31, 2020 | 418,758.00 |